GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
122 hedge funds and large institutions have $826M invested in Genomic Health, Inc. in 2015 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 59 increasing their positions, 23 reducing their positions, and 5 closing their positions.
Holders
122
Holders Change
+10
Holders Change %
+8.93%
% of All Funds
3.29%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
15
Increased
59
Reduced
23
Closed
5
Calls
$1.33M
Puts
$1.1M
Net Calls
+$231K
Net Calls Change
+$9.07M
Top Buyers
| 1 |
DM
1
Deerfield Management
New York
|
$32.9M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$34.6M |
| 3 |
3
Renaissance Technologies
New York
|
$7.43M |
| 4 |
4
Goldman Sachs
New York
|
$7.49M |
| 5 |
5
Millennium Management
New York
|
$12.2M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TI
126
Trexquant Investment
Stamford,
Connecticut
| – | -$672K | -22,000 | Closed |
|
127
Creative Planning
Overland Park,
Kansas
| – | -$43K | -1,400 | Closed |
|